Myovant stock pops as Sumitovant to acquire remaining stake for $1.7B

Oct. 24, 2022 6:37 AM ETMyovant Sciences Ltd. (MYOV), DNPUFBy: Ravikash, SA News Editor10 Comments

Female patient speaking with her paediatrician in a doctors office


Japan's Sumitovant Biopharma is acquiring the remaining 48% stake in Myovant Sciences (NYSE:MYOV) for $1.7B, which it currently does not own to take the London-based women's health company private.

Sumitovant, a unit of Sumitomo Pharma (OTCPK:DNPUF), will acquire all outstanding

Recommended For You

Comments (10)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.